EPITHERAPEUTICS ApS
Nøgletal
- Afkastningsgrad
- 0,2 %
- Egenkapitalforrentning
- -228,9 %
- Likviditetsgrad
- 139,2 %
- Soliditetsgrad
- 28,1 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | 72.058 |
Driftsresultat | 72.058 |
Finansielle indtægter | 977.343 |
Finansielle omkostninger | 123.818 |
Skat af årets resultat | 21.999.244 |
Årets resultat | -21.073.661 |
Balance
| Regnskabsperiode | |
|---|---|
Likvider | 31.315.549 |
Kortfristede aktiver | 32.713.168 |
Aktiver i alt | 32.713.168 |
Egenkapital | 9.205.571 |
Forpligtelser i alt | 23.507.597 |
Kortfristede forpligtelser | 23.507.597 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Andre kortfristede tilgodehavender | 428 |
Leverandørgæld | 185.997 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 4.545.875 |
Overført resultat | 4.659.696 |
Højdepunkter fra årsrapporten
Forretning og udvikling
Main activity
At the extraordinary general meeting on 10 October 2016, it was decided to dissolve the Company under…
Development in the year
The income statement of the Company for 2021 shows a loss of DKK 21,073,661, the majority of which…
Liquidator’s Review
Risici og væsentlige forhold
Uncertainty relating to recognition and measurement
Recognition and measurement in the Annual Report have not been subject to any uncertainty. Covid 19
has had no impact on the Company.
Unusual events
The financial position of the Company at 31 December 2021, and the results of the activities of the
Company for the financial year for 2021 have not been affected by any unusual events.
No events materially affecting the assessment of the annual report have occurred after the balance sheet
date. It is expected that the liquidation of the company will be finalized within 2022.
Forpligtelser og sikkerhedsstillelser
Contingent assets, liabilities and other financial obligations
Contingent liabilities…
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger